- Home
- TREE vs REPL Comparison
TREE vs REPL Comparison
Compare TREE & REPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TREE
- REPL
- Stock Information
- Founded
- TREE 1996
- REPL 2015
- Country
- TREE United States
- REPL United States
- Employees
- TREE N/A
- REPL N/A
- Industry
- TREE Finance: Consumer Services
- REPL Biotechnology: Pharmaceutical Preparations
- Sector
- TREE Finance
- REPL Health Care
- Exchange
- TREE Nasdaq
- REPL Nasdaq
- Market Cap
- TREE 549.4M
- REPL 578.4M
- IPO Year
- TREE N/A
- REPL 2018
- Fundamental
- Price
- TREE $38.70
- REPL $7.71
- Analyst Decision
- TREE Buy
- REPL Strong Buy
- Analyst Count
- TREE 8
- REPL 6
- Target Price
- TREE $64.13
- REPL $20.00
- AVG Volume (30 Days)
- TREE 531.2K
- REPL 1.1M
- Earning Date
- TREE 05-01-2025
- REPL 05-19-2025
- Dividend Yield
- TREE N/A
- REPL N/A
- EPS Growth
- TREE N/A
- REPL N/A
- EPS
- TREE N/A
- REPL N/A
- Revenue
- TREE $972,179,000.00
- REPL N/A
- Revenue This Year
- TREE $14.31
- REPL $31.16
- Revenue Next Year
- TREE $7.39
- REPL N/A
- P/E Ratio
- TREE N/A
- REPL N/A
- Revenue Growth
- TREE 51.96
- REPL N/A
- 52 Week Low
- TREE $34.55
- REPL $4.92
- 52 Week High
- TREE $62.49
- REPL $17.00
- Technical
- Relative Strength Index (RSI)
- TREE 39.00
- REPL 39.21
- Support Level
- TREE $36.71
- REPL $6.93
- Resistance Level
- TREE $54.81
- REPL $10.30
- Average True Range (ATR)
- TREE 2.86
- REPL 0.73
- MACD
- TREE -1.24
- REPL -0.07
- Stochastic Oscillator
- TREE 10.99
- REPL 23.15
About TREE LendingTree Inc.
LendingTree Inc. is a U.S.-based company that mainly operates an online loan marketplace. The company offers online tools and resources to help consumers find loans or other credit-based products, including mortgage loans, reverse mortgages, home equity loans, personal loans, auto loans, credit cards, student loans, small business loans, and various related products. It provides consumers with direct access to a wide array of lenders. The company has three reportable segments: Home, Consumer, and Insurance. It generates match fees by connecting consumers with lenders and closing fees from lenders when a transaction is finalized. The company conducts business solely in the United States.
About REPL Replimune Group Inc.
Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3.